QUZAMTY
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

QUZAMTY Trademark

Serial Number: 99895722

QUZAMTY is a trademark filed by Shanghai Aucta Pharmaceuticals Co., Ltd. on June 19, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Shanghai Aucta Pharmaceuticals Co., Ltd. (11 trademarks)

No. 10, Lane 100, Banxia Road, Pudong New Area
Shanghai 201318 , CN

Entity Type: 99

Trademark Details

Filing Date

June 19, 2026

Registration Date

Not Registered

Goods & Services

Ophthalmologic preparations; Allergy medication; Pharmaceutical preparations, namely, appetite suppressants; Bronchodilators; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical agents affecting metabolism; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Chemical reagents for medical use

Filing History

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 19, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 19, 2026 MAFR
NEW APPLICATION ENTERED
Jun 19, 2026 NWAP